Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Roivant Sciences Ltd. | ROIV | 14.31M | $506.4M |
Revolution Medicines, Inc. | RVMD | 13.55M | $2.54B |
Exelixis, Inc. | EXEL | 13.47M | $732.79M |
Tango Therapeutics, Inc. | TNGX | 12.28M | $383.78M |
BridgeBio Pharma, Inc. | BBIO | 10.74M | $800.14M |
Boston Scientific Corporation | BSX | 10.52M | $449.04M |
Beam Therapeutics Inc. | BEAM | 10.24M | $351.31M |
Crinetics Pharmaceuticals, Inc. | CRNX | 8.99M | $336.37M |
Liquidia Corporation | LQDA | 8.37M | $666.94M |
| EA ELECTRONIC ARTS INC | EA | 7.92M | $1.62B |
Protagonist Therapeutics, Inc. | PTGX | 6.35M | $778.25M |
Agios Pharmaceuticals, Inc. | AGIO | 5.92M | $219.59M |
Immunovant, Inc. | IMVT | 5.8M | $223.67M |
Lantheus Holdings, Inc. | LNTH | 5.58M | $619.43M |
Acadia Healthcare Company, Inc. | ACHC | 4.22M | $124.64M |
GRAIL Inc. | GRAL | 4.16M | $284.11M |
KKR & Co. Inc. | KKR | 4.12M | $377.98M |
Aramark | ARMK | 3.63M | $206.3M |
Amazon.com, Inc. | AMZN | 2.63M | $627.55M |
Novo Nordisk A/S | NVO | 2.62M | $125.55M |